Am J Transplant, Volume 22, Suppl 3 Archives - Page 58 of 190 - ATC Abstracts

2022 American Transplant Congress
Mitochondrial Dysfunction and Alloimmunity in Chronic Lung Transplant Rejection
M. Cano¹, D. Zhou², C. Chen³, K. Pugh⁴, D. Byers¹, D. Kreisel⁵, R. Hachem¹, A. Gelman⁵
¹Pulmonary and Critical Care, Washington University, Saint Louis, MO, ²Surgery, Washington University, Saint Louis, MO, ³Pulmonary and Critical Care, UT Southwestern Medical Center, Dallas, TX, ⁴Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, ⁵Surgery and Immunology and Pathology, Washington University, Saint Louis, MO
*Purpose: Bronchiolitis obliterans syndrome (BOS) remains a major cause of death after lung transplantation. Unfortunately, we lack effective treatments for BOS as the mechanisms by…
2022 American Transplant Congress
Functional Status Assessment in Kidney Transplant Candidates and Recipients: A Single-Center Experience
M. Marshall, O. A. Moss, G. Friedman, O. A. Moss
UC Davis Transplant Center, Sacramento, CA
*Purpose: Functional status assessment (FSA) is important to kidney transplant (KT) candidacy evaluation; a low Fried Frailty score (FFS) is associated with poor waitlist and…
2022 American Transplant Congress
Managing Medications During a Pandemic: A Mixed-Methods Study of Perception of Adult Kidney Transplant Recipients and Those Waiting for a Kidney Transplant
M. R. Wakefield¹, C. M. Ashbaugh², C. Richardson², M. B. Stephens², P. Yerram³, M. Freiburghaus⁴, M. Mercedes⁴, C. L. Russell⁴
¹Surgery/Urology, University of Missouri School of Medicine, Columbia, MO, ²Transplant, University of Missouri Health Care, Columbia, MO, ³Nephrology, Harry S Truman VA Hospital, Columbia, MO, ⁴University of Missouri-Kansas City, Kansas City, MO
*Purpose: Patients interact with healthcare providers (HCP) and pharmacists to manage medications. Little is known about the impact of COVID-19 on medication management. The purpose…
2022 American Transplant Congress
Safety and Mortality Benefit of Direct Oral Anticoagulants in Kidney Transplant
C. Firth, M. Apolinario, F. Shamoun, E. Lim, N. Zhang, M. Keddis
Mayo Clinic, Scottsdale, AZ
*Purpose: Direct oral anticoagulants (DOACs) are increasingly used in renal transplant recipients (RTR). We aim to identify bleeding events and all-cause mortality between DOACs and…
2022 American Transplant Congress
Impact of Sub-therapeutic Tacrolimus Troughs at Discharge from Index Admission on Short-Term Outcomes in Kidney Transplant Recipients Receiving Rabbit Anti-Thymocyte Globulin Induction
X. Liu¹, J. Trofe-Clark², D. Sawinski³, B. Steiner¹, S. Sharma¹, S. Witek¹, T. Fallah², M. Norris², C. Sammons², G. Malat²
¹Pharmacy, Hosp of Univ of Pennsylvania, Philadelphia, PA, ²Penn Transplant Institute and Pharmacy Dept, Hosp of Univ of Pennsylvania, Philadelphia, PA, ³Penn Transplant Institute, Hosp of Univ of Pennsylvania, Philadelphia, PA
*Purpose: Kidney transplant (KTx) recipients are often discharged with subtherapeutic tacrolimus (TAC) troughs due to short hospital lengths of stay (LOS) for index KTx admissions.…
2022 American Transplant Congress
Racial Differences in the Predictability of Donor-Derived Cell-Free DNA Among Renal Transplant Recipients
M. D. Williams¹, N. Nimmagadda¹, S. Patel², O. Olaitan¹
¹Rush University Medical Center, Chicago, IL, ²CareDx, Brisbane, CA
*Purpose: Donor-Derived Cell-Free DNA (dd-cfDNA) is used to monitor for allograft rejection following renal transplantation. Baseline dd-cfDNA is higher in African American (AA) patients compared…
2022 American Transplant Congress
Outcomes in Elderly Black Renal Transplant Recipients Receiving Basiliximab Induction and Early Steroid Withdrawal
E. Garcia, T. Sparkes, A. Szczepanik, S. Bova, J. Bromberg, A. Haririan, J. Casale
University of Maryland Medical Center, Baltimore, MD
*Purpose: Black renal transplant recipients (RTR) carry a higher risk of rejection (BPAR) and graft loss due to immunologic and non-immunologic factors. Lymphocyte depleting induction…
2022 American Transplant Congress
Renal Allograft Lymphangiectasia: A Rare Post-Transplant Complication
M. M. Ibrahim¹, R. Delos Santos¹, A. Java²
¹Medicine/Nephrology, Washington University in St. Louis, St. Louis, MO, ²Washington University School of Medicine in St. Louis, Saint Louis, MO
*Purpose: Lymphangiectasia of the kidney is a rare condition characterized by benign intrarenal or extrarenal dilatation of lymphatics in the peripelvic and the perinephric regions.…
2022 American Transplant Congress
Adult-to-Adult Living Donor Liver Transplantation in Acute Liver Failure – Do Outcomes Justify the Risks?
A. Shingina¹, I. A. Ziogas², P. Vutien³, E. Uleryk⁴, E. Renner⁵, M. P. Bhat⁶, J. Tinmouth⁴, J. Kim⁷
¹Vanderbilt University, Nashville, TN, ²Division of Hepatobiliary Surgery and Liver Transplantation, Vanderbilt University Medical Center, Nashville, TN, ³University of Washington Medical Center, Seattle, WA, ⁴University of Toronto, Toronto, ON, Canada, ⁵University of Manitoba, Saskatchewan, MB, Canada, ⁶Multi-Organ Transplant, UHN, Toronto, ON, Canada, ⁷Toronto General Hospital, Toronto, ON, Canada
*Purpose: Living-donor Liver Transplantation(LDLT) has emerged as a safe and effective alternative in children and adults with pre-existing liver diseases. Utilization of LDLT for patients…
2022 American Transplant Congress
Voxelated Bioprinting of Mechanically Robust Multiscale Porous Scaffolds for Islet Transplantation
J. Zhu, Y. He, Y. Wang, J. Oberholzer, L. Cai
University of Virginia, Charlottesvle, VA
*Purpose: Classical microencapsulation technologies for islet transplantation faces two major challenges associated with individual microcapsules. First, due to long-term gravity individual microcapsules often aggregate to…